Revenue segments as reported by the company.

Sustain

Launch

PaaS

Liquidate/Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and distribution

Research and development

General and administrative

Impairment loss on goodwill

Impairment loss on intangibles

Settlement of a contingent earnout liability

Change in fair value of contingent earn-out liabilities

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aterian

Aterian, Inc. is a technology enabled consumer products company. The company's brands include hOme, Vremi, Xtava and RIF6. Its product categories include home and kitchen appliances, kitchenware, environmental appliances, beauty related products and consumer electronics. The company was founded by Yaniv Sarig Zion in 2014 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Aterian reports Q1 revenue decline but eyes profitability in 2024

Aterian's Q1 2024 performance reflects challenges in revenue decline but shows progress in margin improvement and cost management.
The company's strategic focus on core business improvements and expansion into new markets presents growth opportunities.
Efforts to achieve adjusted EBITDA profitability in the second half of 2024 signal a path towards financial stability and growth.

Aterian reports mixed Q3 results, eyes strategic growth in 2025

Aterian's Q3 performance showcased a mixed picture with revenue decline but improved EBITDA, driven by successful product lines. The company's strong brand portfolio, cash balance, and strategic focus on quality and growth present a solid foundation for future success. While challenges like shipping costs persist, Aterian's proactive approach and upcoming initiatives offer promising opportunities for growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aterian, Inc. is a technology enabled consumer products company. The company's brands include hOme, Vremi, Xtava and RIF6. Its product categories include home and kitchen appliances, kitchenware, environmental appliances, beauty related products and consumer electronics. The company was founded by Yaniv Sarig Zion in 2014 and is headquartered in Summit, NJ.

Aterian, Inc. (NASDAQ:ATER ) Q3 2024 Earnings Conference Call November 11, 2024 5:00 AM ET Company Participants Ilya Grozovsky - VP, IR & Corporate Development Arturo Rodriguez - CEO Josh Feldman - CFO Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Marvin Fong - BTIG Operator Thank you for standing by. My name is Bella and I will be your conference operator today.

Aterian, Inc. (ATER) Q3 2024 Earnings Call Transcript

Third Quarter Net Loss Improved by 71.7% Year Over Year Achieved Adjusted EBITDA Profit for the Second Consecutive Quarter, Marking a $4.9 Million Improvement Year-Over-Year SUMMIT, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2024.

Aterian Reports Third Quarter 2024 Results

Aterian's changed leadership team has brought a new necessary refined approach. After a tumultuous few years, green shoots have appeared in recent financial results. The market price isn't fully accounting for Aterian's progress in the first half of the year, or its future prospects.

Aterian's Prospects Are Improving Under New Leadership - Buy

SUMMIT, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its third quarter 2024 financial results after the market close on Monday, November 11, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

Aterian Sets Date for Third Quarter 2024 Earnings Announcement & Investor Conference Call

Aterian, Inc. (NASDAQ:ATER ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Arturo Rodriguez - Chief Executive Officer Josh Feldman - Chief Financial Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Alex Furman - Craig Hallum Capital Group Operator Thank you for standing by. My name is Kathy and I will be your conference operator today.

Aterian, Inc. (ATER) Q2 2024 Earnings Call Transcript

SUMMIT, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2024 financial results after the market close on Thursday, August 8, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

Aterian Sets Date for Second Quarter 2024 Earnings Announcement & Investor Conference Call

After the close of Wednesday's regular session, e-commerce brand consolidator Aterian raised Q2 expectations for botth the top- and bottom line. Following years of revenue declines and material cash burn, the company is finally showing signs of life. At the high-end of the increased range, the company would break-even on an Adjusted EBITDA basis for the first time since Q3/2021.

Aterian: Cheap, But Speculative Turnaround Play - Upgrade To Buy

Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the appointment of Arturo (Arty) Rodriguez as Chief Executive Officer (previously the Company's Co-CEO and CFO) and Josh Feldman as Chief Financial Officer (previously the Company's SVP of Finance) and that Joe Risico has resigned as Co-CEO and from the Board of Directors and will consult the Company over a three month transition period. “On behalf of our Board of Directors, we express our deep gratitude for Joe's passion, innovative ideas, and relentless work ethic.

Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges

NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Limited Canada (“CPL” or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. Based in Mississauga, Ontario, Canada, CPL is an industry leader with longstanding relationships with 15 of the top.

Aterian Investment Partners Acquires Contract Pharmaceuticals Limited

Aterian, Inc. (NASDAQ:ATER ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, IR & Corporate Development Joseph Risico - Co-CEO Arturo Rodriguez - Co-CEO & CFO Conference Call Participants Brian Kinstlinger - Alliance Global Partners Marvin Fong - BTIG Operator Thank you for standing by. My name is Alex, and I will be your conference operator today.

Aterian, Inc. (ATER) Q1 2024 Earnings Call Transcript

First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the first quarter ended March 31, 2024.  First Quarter Highlights First quarter 2024 net revenue declined 42.0% to $20.2 million, compared to $34.9 million in the first  quarter of 2023.

Aterian Reports First Quarter 2024 Results

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its first quarter 2024 financial results after the market close on Tuesday, May 7, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference Call

First Quarter Net Revenue Range Improved to $20.0 Million to $21.0 Million First Quarter Adjusted EBITDA Loss Range Improved to ($2.4) Million to ($2.9) Million NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) --  Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced updates to its previously announced net revenue and Adjusted EBITDA ranges for the first quarter of 2024 ended March 31, 2024. The net revenue and Adjusted EBITDA information is based on preliminary data, which has not been subjected to normal quarter end closing and review procedures.

Aterian Announces Improved First Quarter 2024 Net Revenue and Adjusted EBITDA Ranges

NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement to recapitalize Contract Pharmaceuticals Limited Canada ("CPL" or the “Company”), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. CPL, based in Mississauga, Ontario, Canada, is an industry leader with longstanding relationships w.

Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization

Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024 Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024

Aterian Announces Reverse Stock Split

Aterian, Inc. (ATER) Q4 2023 Earnings Call Transcript

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2023.  Fourth Quarter 2023 Highlights Fourth quarter 2023 net revenue declined 40.3% to $32.8 million, compared to $54.9 million in the fourth quarter of 2022.

Aterian Reports Fourth Quarter & Full Year 2023 Results

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the recent closing of a strategic minority equity investment in 4th & Heart, the leading U.S. maker of premium ghee butter products. The Company invested approximately $0.2 million in cash and approximately 145,000 shares of Aterian common stock.

Aterian Makes Strategic Minority Equity Investment in 4th & Heart

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its fourth quarter and full year 2023 financial results after the market close on Tuesday, March 12, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call

Credit Facility's Financial Liquidity Covenant More Favorable Maturity Extended to December 2026 NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced that it has extended its asset backed credit facility (“Credit Facility”) with MidCap Financial, which is managed by a subsidiary of Apollo Global Management, Inc. The Credit Facility term has been extended to December 2026 and gives Aterian access to $17.0 million in current commitments which can be increased, subject to certain conditions, to $30.0 million. The Credit Facility extension reduces the minimum liquidity financial covenant from a peak of $15.0 million to $6.8 million of cash on hand and/or availability in the Credit Facility.

Aterian Further Strengthens Its Balance Sheet With Extension Of Its Credit Facility

Expected to Save $4.0 Million Annualized On Target for Second Half 2024 Adjusted EBITDA Profitability Fourth Quarter 2023 Net Revenue Range Improved to $31.2 Million to $32.0 Million Expected Adjusted EBITDA Loss Range Improved to $(6.3) Million to $(5.5) Million NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced a fixed cost reduction as part of the final steps of its previously announced SKU rationalization program. The Company also released certain preliminary fourth quarter 2023 results.

Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 Results

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Squatty Potty, the toilet stool that positions people how nature intended, reducing their strain while eliminating, announced that select Squatty Potty toilet stools have launched in Walmart stores nationwide. Squatty Potty is a 100% owned brand of Aterian, Inc. (Nasdaq: ATER).

Squatty Potty Re-Launches In Walmart Stores Nationwide

Aterian, Inc. (NASDAQ:ATER ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Joe Risico - Co-Chief Executive Officer Arturo Rodriguez - Co-Chief Executive Officer Conference Call Participants Mike Zabran - ROTH MKM Brian Kinstlinger - Alliance Global Partners Ilya Grozovsky Thank you for joining us today to discuss Aterian's Third Quarter 2023 Earnings Results. On today's call are Joe Risico and Arturo Rodriguez, our Co-CEOs.

Aterian, Inc. (ATER) Q3 2023 Earnings Call Transcript

Reports Third Quarter 2023 Net Revenue of $39.7 Million Third Quarter Net Loss Improves by 94.6% Year Over Year While Adjusted EBITDA Loss Improves by 51.3 % NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the third quarter ended September 30, 2023.  Third Quarter Highlights Third quarter 2023 net revenue declined 40.2% to $39.7 million, compared to $66.3 million in the third quarter of 2022.

Aterian Reports Third Quarter 2023 Results

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2023 financial results after the market close on Wednesday, November 8, 2023, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.

News for Aterian Stock (ATER)